It is distinguished from MFT because of its clear-cut neoplastic appearance and because of nuclear beta-catenin accumulation by immunohistochemistry due to frequent CTNNB1 (beta-catenin gene) mutation in the mesenchymal component of the tumor. This evidence concerns the gene CTNNB1 and neoplasm.